— Know what they know.
Not Investment Advice

Financial News

Sentiment -32.9 4750 articles 2322 bullish 1253 bearish Full Index →
📰

Standard Dental Labs Inc. Engages Strategic Advisor to Support Lab Acquisition Strategy

ORLANDO, Fla., March 23, 2026 (GLOBE NEWSWIRE) -- Standard Dental Labs Inc. ("SDL" or the "Company") today announced it has entered into an...
Why Are Palantir Shares Surging On Monday?

Why Are Palantir Shares Surging On Monday?

Palantir Technologies Inc. (NASDAQ:PLTR) shares are climbing Monday. The rally follows a mix of geopolitical relief and significant military contract...
TNXP: ~2500 Patients Have Initiated Treatment with Tonmya Fo

TNXP: ~2500 Patients Have Initiated Treatment with Tonmya Following November 2025 Commercial Launch

By David Bautz, PhD NASDAQ: TNXP READ THE FULL TNXP RESEARCH REPORT Business Update Encouraging Initial Data from Tonmya™ Launch Following the...
FDA Approves BMY's Opdivo Label Expansion in Classical Hodgk

FDA Approves BMY's Opdivo Label Expansion in Classical Hodgkin Lymphoma

Bristol Myers expands Opdivo's reach with new U.S. and EU approvals in Hodgkin lymphoma, strengthening its immunotherapy leadership and growth...
FDA Approves BMY's Opdivo Label Expansion in Classical Hodgk

FDA Approves BMY's Opdivo Label Expansion in Classical Hodgkin Lymphoma

Bristol Myers expands Opdivo's reach with new U.S. and EU approvals in Hodgkin lymphoma, strengthening its immunotherapy leadership and growth...
FDA Approves BMY's Opdivo Label Expansion in Classical Hodgk

FDA Approves BMY's Opdivo Label Expansion in Classical Hodgkin Lymphoma

Bristol Myers expands Opdivo's reach with new U.S. and EU approvals in Hodgkin lymphoma, strengthening its immunotherapy leadership and growth...
FDA Approves BMY's Opdivo Label Expansion in Classical Hodgk

FDA Approves BMY's Opdivo Label Expansion in Classical Hodgkin Lymphoma

Bristol Myers expands Opdivo's reach with new U.S. and EU approvals in Hodgkin lymphoma, strengthening its immunotherapy leadership and growth...
📰

FDA Clears NVO's Higher Dose of Wegovy: Diversify With These Health ETFs

Novo Nordisk's FDA nod for higher-dose Wegovy could boost healthcare ETFs' appeal, offering diversified exposure to the obesity drug market.
📰

FDA Clears NVO's Higher Dose of Wegovy: Diversify With These Health ETFs

Novo Nordisk's FDA nod for higher-dose Wegovy could boost healthcare ETFs' appeal, offering diversified exposure to the obesity drug market.
📰

FDA Clears NVO's Higher Dose of Wegovy: Diversify With These Health ETFs

Novo Nordisk's FDA nod for higher-dose Wegovy could boost healthcare ETFs' appeal, offering diversified exposure to the obesity drug market.
Intuitive Surgical vs. Stryker: Which Surgical Tech Stock Le

Intuitive Surgical vs. Stryker: Which Surgical Tech Stock Leads?

ISRG outpaces SYK with stronger growth, robotic surgery dominance, and recurring revenue strength, highlighting its edge in MedTech innovation and...
Intuitive Surgical vs. Stryker: Which Surgical Tech Stock Le

Intuitive Surgical vs. Stryker: Which Surgical Tech Stock Leads?

ISRG outpaces SYK with stronger growth, robotic surgery dominance, and recurring revenue strength, highlighting its edge in MedTech innovation and...
FuelCell Energy Eyes Data Center Gold Rush With Rapid-Deploy

FuelCell Energy Eyes Data Center Gold Rush With Rapid-Deploy Power Blocks

FuelCell Energy Inc. (NASDAQ:FCEL) shares rose Monday after the company introduced a standardized 12.5-megawatt on-site power solution aimed at...
This APA Analyst Is No Longer Bearish; Here Are Top 2 Upgrad

This APA Analyst Is No Longer Bearish; Here Are Top 2 Upgrades For Monday

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades...
DWTX: 143 Patients Enrolled in Phase 2b Trial of Halneuron®;

DWTX: 143 Patients Enrolled in Phase 2b Trial of Halneuron®; Results Expected in 3Q26

By David Bautz, PhD NASDAQ: DWTX READ THE FULL DWTX RESEARCH REPORT Business Update 143 Patients Enrolled in Phase 2b Trial of Halneuron® in CINP;...
DWTX: 143 Patients Enrolled in Phase 2b Trial of Halneuron®;

DWTX: 143 Patients Enrolled in Phase 2b Trial of Halneuron®; Results Expected in 3Q26

By David Bautz, PhD NASDAQ: DWTX READ THE FULL DWTX RESEARCH REPORT Business Update 143 Patients Enrolled in Phase 2b Trial of Halneuron® in CINP;...
📰

Roche eröffnet neues Forschungsgebäude für das Institute of Human Biology und leistet damit Pionierarbeit im Bereich menschlicher Modellsysteme, um Entwicklung von Medikamenten zu beschleunigen

Basel, 23. März 2026 – Roche (SIX: RO, ROP; OTCQX: RHHBY) hat heute die Einweihung des neuen Forschungsstandorts des Institute of Human Biology...
📰

Roche inaugurates new research home for the Institute of Human Biology, pioneering human model systems to accelerate drug discovery and development

Basel, 23 March 2026 - Roche (SIX: RO, ROP; OTCQX: RHHBY) announced today the inauguration of the new research home for the Institute of Human...
📰

Sisram Medical Reports Solid Growth in 2025

Solid growth driven by strong performance in international markets, with the injectables business accelerating rapidlyDAXXIFY shows promising results...
📰

Sisram Medical Reports Solid Growth in 2025

Solid growth driven by strong performance in international markets, with the injectables business accelerating rapidly DAXXIFY shows promising...
GSK's Risvutatug Rezetecan Gets Japan Orphan Drug Tag for Lu

GSK's Risvutatug Rezetecan Gets Japan Orphan Drug Tag for Lung Cancer

GSK secures Japan orphan drug status for risvutatug rezetecan in SCLC, adding to multiple global designations backed by promising early data.
GSK's Risvutatug Rezetecan Gets Japan Orphan Drug Tag for Lu

GSK's Risvutatug Rezetecan Gets Japan Orphan Drug Tag for Lung Cancer

GSK secures Japan orphan drug status for risvutatug rezetecan in SCLC, adding to multiple global designations backed by promising early data.
GSK's Risvutatug Rezetecan Gets Japan Orphan Drug Tag for Lu

GSK's Risvutatug Rezetecan Gets Japan Orphan Drug Tag for Lung Cancer

GSK secures Japan orphan drug status for risvutatug rezetecan in SCLC, adding to multiple global designations backed by promising early data.
GSK's Risvutatug Rezetecan Gets Japan Orphan Drug Tag for Lu

GSK's Risvutatug Rezetecan Gets Japan Orphan Drug Tag for Lung Cancer

GSK secures Japan orphan drug status for risvutatug rezetecan in SCLC, adding to multiple global designations backed by promising early data.
Why Are SoFi Technologies Shares Trading Higher On Monday?

Why Are SoFi Technologies Shares Trading Higher On Monday?

SoFi Technologies Inc (NASDAQ:SOFI) shares are gaining ground Monday morning. The digital lender is recovering from a volatile week. Bearish...
ECL to Boost Data Center AI Cooling Platform With CoolIT Acq

ECL to Boost Data Center AI Cooling Platform With CoolIT Acquisition

Ecolab's $4.75B CoolIT deal boosts its AI data center cooling push, expanding into high-growth liquid cooling and unlocking recurring revenue...
ECL to Boost Data Center AI Cooling Platform With CoolIT Acq

ECL to Boost Data Center AI Cooling Platform With CoolIT Acquisition

Ecolab's $4.75B CoolIT deal boosts its AI data center cooling push, expanding into high-growth liquid cooling and unlocking recurring revenue...
ECL to Boost Data Center AI Cooling Platform With CoolIT Acq

ECL to Boost Data Center AI Cooling Platform With CoolIT Acquisition

Ecolab's $4.75B CoolIT deal boosts its AI data center cooling push, expanding into high-growth liquid cooling and unlocking recurring revenue...
Why Aurinia Pharmaceuticals Stock Is Surging Monday Morning

Why Aurinia Pharmaceuticals Stock Is Surging Monday Morning

Aurinia Pharmaceuticals Inc (NASDAQ:AUPH) shares are trading higher Monday morning after the company announced a major leadership transition that...
Broadcom Launches Symantec CBX: Bringing Elite AI Security T

Broadcom Launches Symantec CBX: Bringing Elite AI Security To Small Business Budgets

Broadcom Inc (NASDAQ:AVGO) is expanding its growth strategy by strengthening both cybersecurity offerings and AI infrastructure...
Dow Jumps Over 800 Points; Chicago Fed National Activity Ind

Dow Jumps Over 800 Points; Chicago Fed National Activity Index Declines In February

U.S. stocks traded higher this morning, with the Dow Jones gaining more than 800 points on Monday. Following the market opening Monday, the Dow...
Dow Jumps Over 800 Points; Chicago Fed National Activity Ind

Dow Jumps Over 800 Points; Chicago Fed National Activity Index Declines In February

U.S. stocks traded higher this morning, with the Dow Jones gaining more than 800 points on Monday. Following the market opening Monday, the Dow...
Dow Jumps Over 800 Points; Chicago Fed National Activity Ind

Dow Jumps Over 800 Points; Chicago Fed National Activity Index Declines In February

U.S. stocks traded higher this morning, with the Dow Jones gaining more than 800 points on Monday. Following the market opening Monday, the Dow...
Dow Jumps Over 800 Points; Chicago Fed National Activity Ind

Dow Jumps Over 800 Points; Chicago Fed National Activity Index Declines In February

U.S. stocks traded higher this morning, with the Dow Jones gaining more than 800 points on Monday. Following the market opening Monday, the Dow...
Apogee Therapeutics Stock Rallies On Encouraging Eczema Drug

Apogee Therapeutics Stock Rallies On Encouraging Eczema Drug Data Readout

Apogee Therapeutics Inc. (NASDAQ:APGE) shares are up during Monday’s premarket session following the announcement of 52-week data from the...
U.S. Army Places $52+ Million Order for Skydio X10D, the Lar

U.S. Army Places $52+ Million Order for Skydio X10D, the Largest Single-Vendor Tactical sUAS Order in Army History

SAN MATEO, Calif., March 23, 2026 /PRNewswire/ -- Skydio, the largest U.S. drone manufacturer and world leader in flying robots, announced yesterday...
📰

Why HCA Healthcare (HCA) is a Top Growth Stock for the Long-Term

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
📰

The Cooper Companies (COO) is a Top-Ranked Growth Stock: Should You Buy?

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
📰

Why Solventum (SOLV) is a Top Value Stock for the Long-Term

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Bicycle Therapeutics (BCYC) Loses 19.0% in 4 Weeks, Here's W

Bicycle Therapeutics (BCYC) Loses 19.0% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner

Bicycle Therapeutics (BCYC) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong...
📰

Bet on Winning DuPont Analysis & Pick 5 Top Stocks

Do you have more faith in DuPont analysis than in simple ROE calculation? MYR Group (MYRG), Blue Bird (BLBD), Guardian Pharmacy Services (GRDN),...
Wall Street Analysts Think Cardinal (CAH) Is a Good Investme

Wall Street Analysts Think Cardinal (CAH) Is a Good Investment: Is It?

The average brokerage recommendation (ABR) for Cardinal (CAH) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts...
Wall Street Analysts Think Humacyte, Inc. (HUMA) Is a Good I

Wall Street Analysts Think Humacyte, Inc. (HUMA) Is a Good Investment: Is It?

Based on the average brokerage recommendation (ABR), Humacyte, Inc. (HUMA) should be added to one's portfolio. Wall Street analysts' overly...
Chip Stocks Gain As Trump Hits Pause On Iran Strikes

Chip Stocks Gain As Trump Hits Pause On Iran Strikes

Tech and chip stocks rebounded Monday as easing geopolitical tensions lifted sentiment across the sector. Trump Signals Pause, Diplomacy in...
📰

Trinity Biotech Announces Successful Clinical Results for Its Enhanced EpiCapture™ Prostate Cancer Test

Test Now Incorporates Enhanced Machine Learning Risk Prediction Algorithm  Plans Underway to Commercialise Testing Service Through Trinity...
📰

Trinity Biotech Announces Successful Clinical Results for Its Enhanced EpiCapture™ Prostate Cancer Test

DUBLIN and NEW YORK, March 23, 2026 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB), a global diagnostics company, today announced...
📰

WuXi XDC Delivers Exceptional Performance in 2025, Reinforcing Global Leadership in Bioconjugate CRDMO

Revenue increased by 46.7% YoY to RMB 5,944 million Gross profit surged by 72.5% YoY to RMB 2,139 million, with its margin of 36.0%, a 5.4 percentage...
« Prev 1 25 26 27 28 29 42 Next »

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms